Medtronic announces FDA approval of spinal cord stimulation platform

667542

Sumary of Medtronic announces FDA approval of spinal cord stimulation platform:

  • Medtronic plc has announced FDA approval of the Vanta neurostimulator, an implantable spinal cord stimulation device with up to 11 years of recharge-free battery life, according to a press release..
  • “For those who prefer or require a recharge-free device, I believe the Vanta neurostimulator offers the best hardware and features available today….

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close